Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion · 2018
Epidemiological Profile, Gastrointestinal Toxicity, and Treatment of Pelvic Cancers in Patients Managed with Radiotherapy to the Abdominal Pelvic Area.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cetina-Pérez Lucely, Serrano-Olvera Alberto, Flores-Cisneros Laura, Jiménez-Lima Roberto, Alvarado-Silva Cristina, Díaz-Romero María Del Consuelo, Morales-Vásquez Flavia, Muñoz-González David Eduardo, Mota-García Aida, Chávez-Fierro Oscar Armando, Jaramillo-Manzur Silvia Cristina, de la Garza-Salazar Jaime, Castro-Eguiluz Denisse, Meneses-García Abelardo
Аннотация
Mexico has seen an increase in cancer prevalence in its entire population as well as particular age ranges, predominantly the older segment. The most frequently reported pelvic cancers in Mexico are cervical, endometrial, bladder, prostate, rectum, and anal canal. Approximately 80% of the population diagnosed with pelvic cancers present with locally advanced tumors and require concomitant chemoradiotherapy, sequential chemoradiotherapy, or radiotherapy alone. The toxicity of any of these treatment modalities may be manifested as intestinal injury, a significant problem that can compromise the response to treatment, the patient's nutritional state, quality of life, and survival. In this article, we will approach key aspects in nutrition as well as the epidemiological characteristics and toxicities in patients affected by these pelvic tumors.